Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012:2012:157496.
doi: 10.1155/2012/157496. Epub 2012 Oct 3.

Bone marrow microenvironment in multiple myeloma progression

S Manier  1 , A Sacco, X Leleu, I M Ghobrial, A M Roccaro
Affiliations
Review

Bone marrow microenvironment in multiple myeloma progression

S Manier et al. J Biomed Biotechnol. 2012.

Abstract

Substantial advances have been made in understanding the biology of multiple myeloma (MM) through the study of the bone marrow (BM) microenvironment. Indeed, the BM niche appears to play an important role in differentiation, migration, proliferation, survival, and drug resistance of the malignant plasma cells. The BM niche is composed of a cellular compartment (stromal cells, osteoblasts, osteoclasts, endothelial cells, and immune cells) and a noncellular compartment including the extracellular matrix (ECM) and the liquid milieu (cytokines, growth factors, and chemokines). In this paper we discuss how the interaction between the malignant plasma cell and the BM microenvironment allowed myeloma progression through cell homing and the new concept of premetastatic niche.

PubMed Disclaimer

References

    1. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple Myeloma. Leukemia. 2009;23(1):3–9. - PMC - PubMed
    1. Landgren O, Kyle RA, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple Myeloma: a prospective study. Blood. 2009;113(22):5412–5417. - PMC - PubMed
    1. Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM. A monoclonal gammopathy precedes multiple Myeloma in most patients. Blood. 2009;113(22):5418–5422. - PMC - PubMed
    1. Kyle RA, Durie BG, Rajkumar SV, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple Myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24(6):1121–1127. - PMC - PubMed
    1. Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J., Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple Myeloma. Blood. 2005;106(1):296–303. - PMC - PubMed